|
- Edwards Lifesciences – the leading global structural heart innovation . . .
Transcatheter mitral and tricuspid technologies Critical care technologies* Surgical valve technologies *Edwards Lifesciences Critical Care is now part of BD (Becton, Dickinson and Company)
- Edwards Lifesciences Reaffirms Strategy for Sustainable, Differentiated . . .
Edwards is the only company committed to delivering first-of-its-kind innovations for all of these patients, leveraging our 65 years of leadership and valve expertise
- Who we are - Edwards Lifesciences
Who we are Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives
- Search Jobs | Edwards Lifesciences
Edwards Lifesciences is committed to providing reasonable accommodations and adjustments to individuals with a disability or neurodivergence If you need an accommodation or adjustment during the application, interview, or hiring process, please see the disability accommodation section below
- Global Locations | Edwards Lifesciences
USA and Canada Main locations Global headquarters Edwards Lifesciences Corp One Edwards Way Irvine, CA 92614
- Edwards Lifesciences Reports Fourth Quarter Results
Edwards continues to invest in field-based teams with deep expertise and remains committed to its disciplined approach to launching the therapy, prioritizing excellent patient outcomes
- Surgical structural heart therapies | Edwards Lifesciences
That’s the power of RESILIA tissue For patients, it means a life with the potential to avoid future open-heart surgery * RESILIA tissue gives surgeons the freedom to offer a resilient tissue alternative that brings the quality-of-life benefits of tissue valves to patients Explore the Edwards RESILIA tissue aortic and mitral products below
- Careers | Edwards Lifesciences
Our locations With more than 16,000 employees across the globe, we celebrate our inclusive culture and embrace the diverse perspectives and experiences of our Edwards team No matter your position or location, you will impact the future of our breakthrough medical technologies and industry
|
|
|